首页> 外文期刊>Intellectual Property Counselor >INTELLECTUAL PROPERTY STRATEGY AND BEST PRACTICES IN CHINA AND INDIA LIFE SCIENCES BUSINESS TRANSACTIONS
【24h】

INTELLECTUAL PROPERTY STRATEGY AND BEST PRACTICES IN CHINA AND INDIA LIFE SCIENCES BUSINESS TRANSACTIONS

机译:中国和印度生命科学业务交易中的知识产权策略和最佳实践

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Selecting a trusted partner in China or India with the right IP practices and security infrastructure is a practical means of protecting IP. Injunctive relief, rather than damages, is the most realistic legal remedy in China or India. A patent protecting the product or process must be issued in these countries in order for the U.S. company to seek injunctive relief for patent infringement. Injunctive relief is more readily available for patent infringement than breach of contract. While doing business in China or India has an IP risk, the risk needs to be weighed against the economic benefits. A practical IP strategy and set of best practices can reduce the risk.
机译:在中国或印度选择具有正确的IP实践和安全基础架构的可信赖合作伙伴是保护IP的一种实用方法。在中国或印度,禁令性救济而不是损害赔偿是最现实的法律补救措施。必须在这些国家/地区中授予保护产品或过程的专利,以便美国公司寻求专利侵权的禁令性救济。相比于违约,禁令救济更容易用于专利侵权。在中国或印度开展业务存在IP风险时,需要权衡该风险与经济利益。切实可行的知识产权战略和最佳做法可以降低风险。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号